Moderna Announces Pricing Of Upsized $2.6B 0.00% Convertible Senior Notes Due 2032; Initial Conversion Price $210.58/Share, A 47.5% Premium, With Capped Call Cap At 175% Premium

World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency

https://www.who.int/news/item/28-08-2026-second-meeting-of-the-ihr-emergency-committee-on-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo---meeting-report

This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday

Wall Street analysts upgraded Moderna Inc and Evolution Petroleum Corp, and raised Enbridge's price target. Check out analysts' views on MRNA stock.

Moderna shares are trading lower after the company announced the pricing of its upsized $2.6 billion offering of Convertible Senior Notes.

Moderna Stock Falls Friday: What's Going On?

Shares of Moderna are trading lower Friday morning after the company announced official terms for a major private debt offering.